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Abstract We have purified a novel growth-potentiating factor 
and demonstrated that the factor is coded by the gas6 gene. 
Moreover, we have suggested the presence of a Gas6 receptor on 
rat vascular smooth muscle cells. In this study, we further 
analyzed the binding of Gas6 to its receptor. Tissue and cellular 
distribution of the binding activity of 1251-labeled Gas6 showed 
that the binding site existed in many but a limited range of tissues 
and cell types. Further characterization of the binding of 
[rz51]Gas6 using HOS cells demonstrated that the specific 
binding was dependent on the presence of Ca2+. Chemical 
cross-linking of [lz51jGas6 to HOS cells resulted ln the formation 
of a high-molecular-mass complex, suggesting the presence of a 
high-molecular-weight receptor. 
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1. Introduction 
In a previous paper, we demonstrated purification of a 
y-carboxyglutamic acid (Gla)-containing growth-potentiating 
factor from culture medium of rat vascular smooth muscle 
cells (VSMC) [l]. The factor is encoded by a growth arrest- 
specific gene, gas6 [2,3], which is related to protein S, a nega- 
tive regulator of blood coagulation [4]. Thus, we refer to the 
factor as Gas6. Gas6 does not induce VSMC proliferation by 
itself but potentiates VSMC proliferation stimulated with 
growth factors which activate intracellular signal transduction 
involving Ca2+ mobilization or protein kinase C [l]. Several 
factors such as thrombin, angiotensin II and lysophosphatidic 
acid are involved in this type of growth factor. However, 
Gas6 does not potentiate VSMC proliferation stimulated 
with growth factors which activate receptor tyrosine kinases 
involving epidermal growth factor (EGF) and basic fibroblast 
growth factor (bFGF). Therefore, analysis of the Gas6-in- 
duced signaling mechanism may provide a key to reveal the 
difference between the two types of growth-stimulating signal- 
ing mechanisms. 
In our previous paper, we showed the presence of a specific 
binding site of Gas6 on VSMC membranes using [‘251]Gas6 
[l]. Scatchard analysis of the binding of [1251]Gas6 indicated 
that the Kd value was 0.3 nM, which corresponded well to the 
EC5u value of biological activity of Gas6. This result sug- 
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gested that the action of Gas6 was mediated by a receptor for 
it. On the other hand, recent papers have reported that Gas6 
is a possible ligand for Ax1 receptor tyrosine kinase [5,6], 
whose gene, axl, was originally isolated from myeloid leuke- 
mia cells as a transforming gene [7,8]. Moreover, it has been 
demonstrated that another Axl-related receptor tyrosine ki- 
nase, Sky, also binds Gas6 [9]. These findings suggested that 
VSMC expresses both a ligand and receptor(s), and Gas6 and 
Axl/Sky organize a new ligand-receptor system which regu- 
lates proliferation of VSMC in an autocrine or paracrine fash- 
ion. 
In order to obtain further information about Gas6 action 
from the physiological viewpoint, we examined the tissue and 
cellular distribution of Gas6 receptor and found that a Gas6 
binding site existed in a variety of rat tissues. Furthermore, we 
studied the biochemical characteristics of Gas6 binding to the 
receptor and demonstrated that the binding was largely de- 
pendent on the presence of divalent cations. 
2. Materials and methods 
2.1. Preparation of rat Gas6 and [1251]Gas6 
Rat Gas6 was prepared from culture medium of rat VSMC as 
described in our previous paper [l]. [1251]Gas6 (6000 cpm/fmol) was 
prepared by a chloramine T method as described elsewhere [lo]. 
2.2. Preparation of crude membranes from various tissues 
Rat liver, kidney, spleen, lung, heart, brain, and skeletal muscle, 
and human placenta were isolated and washed with ice-cold buffer A 
(20 mM Tris-HCl, pH 7.4, 2 mM EDTA, 0.4 mM phenylmethylsul- 
fonyl fluoride, 10 mg/ml leupeptin and 0.25 M sucrose). Each tissue 
was minced and suspended in 5 volumes of buffer A, and then homo- 
genized with Physcotron (NITI-ON, Japan) at 4°C. The homogenate 
was centrifuged at 600Xg for 5 min, and crude membrane fractions 
were washed twice with buffer A by centrifuging the supernatant at 
105 000 X g for 60 min at 4°C. The resulting pellet was resuspended in 
buffer A and stored at -80°C until assay. 
2.3. Preparation of crude membranes from various cells 
Cells were harvested with ice-cold buffer A after washing the cells 
with phosphate buffered saline. The cells were suspended in buffer A, 
and then sonicated with a Branson Sonifier (model 350; output setting 
2, twice 15 s). The cell sonicate was centrifuged at 1OOOXg for 10 min 
to remove nuclei and unbroken cells, and the supernatant was further 
centrifuged twice at 105 000 X g for 60 min. The resulting pellet was 
resuspended in buffer A, and used as a crude membrane fraction. 
2.4. Binding experiments 
For binding assays with adhering cells, the confluent cells in 24-well 
dishes were washed twice with washing buffer (1 mM Tris-HCl, pH 
7.4, containing 1 mM EDTA), and incubated with 0.3 nM [1251]Gas6 
at 4°C in 0.2 ml of binding medium (Hanks’ solution, pH 7.4, 0.1% 
bovine serum albumin). After the reaction was stopped by rapid re- 
moval of the medium, the cells were washed three times with ice-cold 
saline, and then solubilized in 1 N NaOH. The radioactivity was 
measured with a y-counter. Specific binding was defined as the differ- 
ence between binding in the presence and absence of the unlabeled 
Gas6 (30 nM). The binding assays in the crude membrane of HOS 
cells were carried out according to the method described previously 
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2.5. Ajinity cross-linking 
Confluent HOS cells grown in 24-well dishes were incubated in 0.2 
ml of the binding medium containing 0.3 nM [lz51]Gas6 with or with- 
out 30 nM unlabeled Gas6 for 2 h at 4°C. After washing three times 
with ice-cold saline, the cells were resuspended in 0.2 ml of Hanks’ 
solution (pH 7.4), and then treated with 0.15 mM disuccinimidyl 
suberate (DSS), a homobifunctional cross-linking reagent, for 30 
min at 4°C. The reaction was stopped by the addition of Tris-HCl 
(final concentration 50 mM, pH 7.4). The cells were harvested and 
lysed with 1% Triton X-100 containing a mixture of protease inhibi- 
tors (1 mM phenylmethylsulfonyl fluoride, 2 mM EDTA and 20 mg/ 
ml leupeptin). The supernatants obtained by centrifugation at 
1OOOOXg for 10 min were mixed with Laemmli sampling buffer and 
heated at 60°C for 5 min, and proteins were separated by SDS-PAGE. 
After electrophoresis, the gel was dried and exposed to Kodak X- 
Omat AR X-ray film for 2 days at -80°C with two intensifying 
screens. 
3. Results and discussion 
In order to study tissue distribution of Gas6 receptor, we 
used membrane fractions prepared from several rat and hu- 
man tissues to analyze [lz51]Gas6 binding. As shown in Table 
1, specific binding of [‘251]Gas6 was detected in the membrane 
fractions of rat spleen, lung, heart and brain, but not in those 
of liver, kidney and skeletal muscle. The membrane fractions 
of human placenta also showed activity to bind Gas6. Next, 
the cellular distribution of Gas6 receptor was examined using 
several types of cultured cells (Table 2). In addition to VSMC 
[l], specific binding of [lz51]Gas6 was observed on some types 
of cells tested. UMR-106 and ROS-1712.8, rat osteosarcoma 
cell lines, did not have the activity to specifically bind 
[1251]Gas6, whereas HOS and MG-63, human osteosarcoma 
cell lines, had relatively high activity of Gas6 binding. These 
results indicate that the Gas6 receptor is present in many but 
a limited range of tissues and cell types. 
Since HOS cells had the highest binding capacity among the 
cell lines listed in Table 2, biochemical analysis of the binding 
of Gas6 to receptor was performed using HOS cells. Both 
intact and membrane fractions of HOS cells bound [1251]Gas6 
and the specific binding was approximately 80% of the total 
binding (data not shown). 
We analyzed the ligand specificity of the Gas6 binding site 
on HOS cells. Table 3 summarizes the IC5,, values of several 
proteins for their ability to displace the specific binding of 0.3 
nM [1251]Gas6. Unlabeled Gas6 inhibited the binding of la- 
beled Gas6 with a low I& value. However, human protein S, 
which has 43% amino acid residue identity with rat Gas6 [l], 
did not suppress Gas6 binding even at concentrations higher 
than 30 nM. Other growth factors such as thrombin, platelet- 
Table 1 
Tissue distribution of Gas6 receptor 
Tissue Specific binding (fmol/mg 
protein) 
Rat liver <l.O 
kidney Cl.0 
heart 2.3 
lung 4.4 
spleen 8.6 
brain 1.4 
skeletal muscle Cl.0 
Human placenta 4.4 
The crude membranes prepared from each tissue (0.2 mg) were incu- 
bated with 0.3 nM [‘251]Gas6 for 2 h at 4°C in the binding medium, 
and the specific binding activity was analyzed as described in section 2. 
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Fig. 1. The Ca’+ dependence of the binding of [‘251]Gas6 to HOS 
cells and equilibrium binding of [1251]Gas6. (A) The cells were incu- 
bated with 0.3 nM [1251]Gas6 for 2 h at 4°C with or without 30 nM 
unlabeled Gas6. The assays were carried out in the presence or ab- 
sence of 10 mM EDTA in the binding medium. **P<O.O5, com- 
pared with -Gas6, -EDTA (Student’s t-test). (B) Scatchard plot of 
specific [1251]Gas6 binding. The cells were incubated with various 
concentrations of [1251]Gas6 alone for 2 h at 4°C (total binding) or 
in the additional presence of a 20-fold amount of unlabeled Gas6 
(non-specific binding). The assays were carried out in the presence 
(open circles) or absence (closed circles) of 10 mM EDTA in the 
binding medium. The data are representative of three experiments, 
and each point represents the mean specific binding for three deter- 
minations. 
derived growth factor (PDGF), EGF and bFGF did not affect 
the binding of [lz51]Gas6. Therefore, the Gas6 receptor ap- 
pears to be highly specific to Gas6. 
Mature Gas6 has 11-12 Gla residues in the N-terminal 
region [l]. Gla residues are found in some proteins regulating 
blood coagulation, which include prothrombin, factor VII, 
factor IX, factor X, protein C and protein S [ll], and inter- 
action with Ca2+ has been expected to be one of the functions 
of Gla residues [12]. Therefore, we examined the effect of 
Ca2+ on the binding activity of Gas6 to HOS cells. Fig. 1A 
shows the effect of EDTA on the binding of [lz51]Gas6 to 
intact HOS cells. Addition of 10 mM EDTA to the binding 
medium containing 1.2 mM Ca2+ suppressed total binding by 
approximately 65%. Non-specific binding was also suppressed 
by EDTA by approximately 35%. Therefore, EDTA inhibited 
the specific binding by approximately 70%. The effect of 
EDTA was overcome by further addition of 10 mM Ca2+ 
(data not shown). 
In order to examine whether EDTA affected binding affinity 
Table 2 
Cellular distribution of Gas6 receptor 
Cells Specific binding (fmoU105 cells) 
Rat VSMC 0.57 
A7r5 0.28 
renal mesangial cell 0.31 
ROS-1112.8 co.02 
UMR-106 co.02 
Human HUVEC 0.33 
HOS 1.33 
MG-63 1.08 
Cells were incubated with 0.3 nM [lz51]Gas6 for 2 h at 4°C in the 
binding medium, and the specific binding activity was analyzed as 
described in section 2. 
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Fig. 2. Characterization of the Gas6 receptor by affinity cross-link- 
ing experiment. Binding assay was carried out at 4°C for 2 h by in- 
cubating HOS cells with 0.3 nM [1251]Gas6 in the absence (lane 1) 
or presence (lane 2) of 30 nM unlabeled Gas6. After the incubation, 
the cells were washed and treated with 0.15 mM DSS for 30 min at 
4”C, and then analyzed as described in section 2. 
or binding capacity, Scatchard analysis was performed using 
membrane fractions of HOS cells in the presence or absence 
of 10 mM EDTA. As shown in Fig. lB, addition of EDTA 
reduced the number of binding sites from 280 fmol/mg protein 
to 35 fmollmg protein, while EDTA had little effect on the 
binding affinity. The & values in the presence and absence of 
EDTA were 1.2 nM and 1.5 nM, respectively. This result 
indicated that divalent cations were almost essential for bind- 
ing of Gas6 to its receptor. 
Identification of the binding proteins responsible for 
[lz51]Gas6 binding was performed by affinity labeling experi- 
ments. After [lz51]Gas6 was incubated with HOS cells for 2 h, 
the cells were treated with DSS and labeled proteins were 
Table 3 
Inhibition of [1251]Gas6 specific binding to HOS cells by protein S 
and other growth factors 
Compound IC5o (nM) 
Gas6 
Protein S 
Thrombin 
PDGF 
EGF 
bFGF 
1.3 
>30 
>50 
>lOO 
>lOO 
>lOO 
Cells were incubated with 0.3 nM [‘251]Gas6 in the presence of various 
concentrations of agents for 2 h at 4°C in the binding medium. The 
IC50 values were evaluated from the displacement curves as the con- 
centration that inhibits half of the [1251]Gas6 specific binding. 
analyzed by SDS-PAGE. As shown in Fig. 2, a band with 
an apparent molecular weight of approximately 300-400 
kDa appeared after treatment with DSS (lane l), whereas 
the formation of the cross-linked complex was blocked by 
the presence of excess unlabeled Gas6 (lane 2). The high-mo- 
lecular-mass complex was not observed in the absence of DSS 
(data not shown). The molecular weight of the cross-linked 
complex agreed well with that of the Gas6/Axl complex de- 
scribed by Varnum et al. [5]. Therefore, the specific binding 
site of Gas6 on HOS cells may be Ax1 or Sky, or another Axl- 
related molecule such as Mer/Eyk [6,9,13]. 
We first isolated Gas6 from the culture medium of rat 
VSMC and implicated the physiological role of Gas6 in the 
proliferation of VSMC via the specific receptor [l]. However, 
as illustrated in Table 1, a specific binding site for Gas6 was 
also found in a variety of rat tissues, such as heart, lung, 
spleen and brain. Moreover, expression of Gas6 mRNA in 
these tissues has been reported [3]. Therefore, Gas6 may 
also have biological importance in tissues other than the aor- 
ta. Neubauer et al. [8] have reported the expression of Ax1 
mRNA in normal and malignant hematopoietic tissues and 
suggested Ax1 kinase may be operative in hematopoiesis. 
Nevertheless, potentiation of VSMC proliferation is the only 
biological activity of Gas6 clearly demonstrated so far [ 11. We 
are now conducting further studies on Gas6-induced biologi- 
cal responses of other tissues and cell types for a better under- 
standing of its biological relevance. 
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